|
|
Volumn 298, Issue 8, 2007, Pages 851-852
|
|
Postmarket "pharmacovigilance" program on alert for adverse events from drugs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOPIDOGREL;
TICLOPIDINE;
BLOOD CLOTTING DISORDER;
CORONARY ARTERY DISEASE;
DRUG INDUSTRY;
DRUG LABELING;
DRUG MONITORING;
DRUG PACKAGING;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MYELOMA;
PERIPHERAL VASCULAR DISEASE;
POSTMARKETING SURVEILLANCE;
PRESCRIPTION;
PRIORITY JOURNAL;
SHORT SURVEY;
STROKE;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
TREATMENT OUTCOME;
ARTICLE;
CANCER CENTER;
INTERDISCIPLINARY COMMUNICATION;
UNITED STATES;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
CANCER CARE FACILITIES;
DRUG INDUSTRY;
INTERDISCIPLINARY COMMUNICATION;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 34548070477
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.298.8.851 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|